| Net loss | -1.33M |
| Depreciation | |
| Amortization of patents and proprietary technology | |
| Impairment of long-term assets | |
| Issuance of common stock and warrants for services | |
| Expenses paid by increase in convertible note payable | |
| Amortization of discount on note payable | 641.87K |
| Stock-based compensation expense for employees | 25.3K |
| Loss on asset disposal | |
| Loss on extinguishment of debt | 0 |
| Loss on conversion of notes payable to common stock | 0 |
| Accounts receivable | -124.78K |
| Inventory | |
| Deposits and prepaid expenses | 2.61K |
| Accounts payable | 29.25K |
| Accounts payable - related parties | 2.16K |
| Accrued liabilities | 273.12K |
| Deferred revenue | |
| Net Cash Used in Operating Activities | |
| Payments for the purchase of equipment | |
| Payments for patents | 0 |
| Payment for acquisition of equipment and proprietary technology from Flexpoint Holdings, LLC | |
| Net Cash Used in Investing Activities | |
| Net proceeds from issuance of common stock and warrants | |
| Proceeds for subscriptions receivable | |
| Principal payments on notes payable - related parties | |
| Proceeds from notes payable - related parties | 20K |
| Proceeds from borrowings under convertible note payable | 380K |
| Net Cash Provided by Financing Activities | |
| Net Change in Cash and Cash Equivalents | -20.31K |
| Cash and Cash Equivalents at Beginning of Period | 22.71K |
| Cash and Cash Equivalents at End of Period | 2.4K |
| Cash paid for interest | 0 |
| Cash paid for income taxes | 0 |
| Stock issued for debt | |
| Outstanding notes payable converted to stock | |
| Expiration of warrants outstanding | |
| Subscription receivable | |
| Recognition of discounts on convertible notes payable | 124.34K |
| Extinguishment of unamortized discount on modified convertible notes payable | |
| Accounts payable converted to notes payable | |